Uptake of Kynurenine into Rat Brain Slices
- 1 January 1990
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 54 (1) , 156-163
- https://doi.org/10.1111/j.1471-4159.1990.tb13296.x
Abstract
The transport of [3H]kynurenine ([3H]KYN) into slices from rat tissue was examined in vitro. Brain accumulated KYN seven to eight times more effectively than any of several peripheral organs. Of all the organs tested, only the brain exhibited a sodium-dependent component of the uptake process. After an incubation period of 1 h, sodium-dependent transport amounted to 60% of total uptake. Both processes were abolished by prior sonication of the tissue and significantly inhibited by inclusion of metabolic blockers in the incubation medium. Time resolution showed that the sodium-independent uptake occurred rapidly and reached saturation within 30 min. In contrast, sodium-dependent transport was linear for at least 2 h of incubation. Brain regional analysis revealed a sevenfold difference between the areas of highest (cortex) and lowest (cerebellum) uptake. With the exception of cerebellar tissue, the ratio between sodium-dependent and sodium-independent processes was consistent among brain regions. Kinetic analyses were performed on striatal slices and revealed a Km of 927 μM and a Vmax of 18 nmol/h/mg of protein for the sodium-dependent process, and a Km of 3.8 mM and a Vmax of 38 nmol/10 min/mg of protein for the sodium-independent transport. The transporters were equally amenable to inhibition by KYN and tryptophan, indicating that KYN entry into the cell may be mediated by neutral amino acid uptake sites. No strict stereoselectivity existed, but L enantiomers were clearly more active than the D forms. Studies in ibotenate-lesioned striata showed a 70%decrease in the sodium-dependent process and a concomitant 60%increase in the sodium-independent transport, suggesting differential cellular associations of the two uptake sites. Cellular uptake of KYN may constitute a critical step in the disposition of KYN metabolites such as quinolinic acid and kynurenic acid in the brain.Keywords
This publication has 32 references indexed in Scilit:
- Effect of kynurenine loading on quinolinic acid production in the rat: Studies andLife Sciences, 1988
- Organic ion transport during seven decades the amino acidsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1984
- Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acidNeuroscience Letters, 1984
- II. Excitotoxic models for neurodegenerative disordersLife Sciences, 1984
- Studies on kynurenine in human cerebrospinal fluid: Lowered levels in epilepsyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNSEuropean Journal of Pharmacology, 1981
- Experimental studies on kynurenines as neuroactive tryptophan metabolites: past, present and futureTrends in Pharmacological Sciences, 1980
- Stimulant and convulsive effects of kynurenines injected into brain ventricles in miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- Cerebral tryptophan‐2,3‐dioxygenase (pyrrolase) and its induction in rat brainJournal of Neurochemistry, 1974
- Transport and further metabolism of intermediate compounds of the tryptophan-nicotinic acid ribonucleotide pathway by rat small intestineBiochimica et Biophysica Acta (BBA) - Biomembranes, 1968